Abstract: Synthesis of beneficial protected meso-DAP 9 by cross metathesis of the Garner aldehyde-derived vinyl glycine 1b with protected allyl glycine 2 in the presence of Grubbs second-generation catalyst was performed. Preparation of lipophilic N-acyl iE-DAP as potent agonists of NOD 1-mediated immune response from 9 is described.
Introduction
Peptidoglycan (PGN) is an essential component of the cell walls of virtually all bacteria. The function of the PGN is to preserve cell integrity by withstanding the internal osmotic pressure [1, 2] . The biosynthesis of PGN is a well-recognized target for antibiotic development [3] . Bacterial cell wall PGN can function as a potent immunostimulator and an adjuvant for antibody production. PGN partial structures are recognized by the intracellular nucleotide-binding oligomerization domain proteins 1 and 2 (NOD1 and NOD2) that mediate host recognition of bacterial molecules [4] [5] [6] . The recognition core of Nod1 stimulatory molecules is γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP) which is a constituent of most Gram-negative and some Gram-positive bacteria. In addition, synthetic, lipophilic, N-acyl iE-DAP derivatives have been shown to be potent NOD 1 agonists [7] . Thus, DAP scaffold OPEN ACCESS peptides would be expected to function as NOD 1 agonists. In connection with our interest in the synthesis of DAP [8] , we report herein on a new synthesis of orthogonally protected meso-DAP and applications to preparing N-acyl iE-DAP from protected iE-DAP ( Figure 1 ).
Figure 1.
Structures of meso-DAP and iE-DAP.
Results and Discussion
Because DAP-containing peptides such as iE-DAP and FK565 [9, 10] have significant biological activities and functions, the synthesis of orthogonally protected meso-DAP as synthetic intermediates has been a subject of considerable interest by several groups [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . However, available methods suffer from several disadvantages, including the use of commercially inaccessible starting materials, harsh reaction conditions, multi steps, and lower product yields. We envisaged that orthogonally protected meso-DAP could be conveniently prepared by a cross metathesis (CM) between the readily available Garner aldehyde-derived vinyl glycine equivalent 1 and protected allyl glycine 2 (Scheme 1).
Scheme 1.
Cross metathesis of Garner aldehyde-derived vinyl glycine equivalents 1 and protected allyl glycine 2.
A variety of substituted olefins 1a-e as vinyl glycine equivalents were obtained from the Garner aldehyde in high yields according to the corresponding literature reports [27] [28] [29] [30] [31] . It is expected that a homocoupling of 1 would scarcely occur due to a bulkiness of N-Boc-oxazolidine. First, a coupling began with the CM of 1a with 2 [32, 33] . Treatment of 1a (5 mmol) with 2 (1 mmol) using the Grubbs second-generation catalyst A (5 mol%, Figure 2 ) in CH 2 Cl 2 under reflux gave a desired product 3 in 56% together with homo-coupling products traces of 4 and 5 (22%) (entry 1 in Table 1 ). All reactions were carried out with a ratio (1a:2 = 5:1) under reflux.
Next, the use of a combination of catalysts B [34] and C [34] gave lower yields (28% and 33%) of 3, respectively (entries 2 and 3). On the other hand, when toluene was used as the solvent in place of CH 2 Cl 2 , a higher yield (64%) of 3 was obtained (entry 4).
In addition, the use of CM using several substituted olefins 1b-e as vinyl glycine units in toluene was examined and the results are shown in Table 2 . The use of 1b (E:Z = 1:10) gave the best yield (76%) of 3. Unfortunately, CM using other derivatives, such as 1c-e, resulted in lower yields (entries 4~6). Furthermore, the CM of 1b with the Hoveyda-Grubbs 2nd generation D [34] and the Blechert E [35] catalysts afforded lower yields (56% and 9%), respectively. Accordingly CM in conjunction with a combination of 1b and A as a catalyst resulted in better yields. Additionally, CM using the pure E isomer and the Z isomer of 1b resulted in nearly the same yields (75%) (entry 7). Furthermore, the CM in Table 2 produced no the homocoupling product 4 as expected.
With 3 in hand, our interest was focused on the synthesis of orthogonally protected meso-DAP. The hydrogenation of 3 in the presence of PtO 2 as a catalyst gave 6, which was transformed by hydrolysis of the amino acetal with with p-TsOH in aqueous MeOH into the alcohol 7 in 81% yield in two steps.
The primary alcohol of 7 was converted into the carboxylic acid 8 by oxidation with TEMPO, which was esterfied, without isolation, with benzyl alcohol using our developed 1-tert-butoxy-2-tertbutoxycarbonyl-1,2-dihydroisoquinoline (BBDI) [36] to yield the fully protected meso-DAP 9 in 94% yield in two-steps. All reactions were carried out with a ratio (1:2 = 5:1) under reflux in toluene.
Having the desired 9 in hand, we embarked on the synthesis of N-acyl iE-DAP, which is known to function as a strong agonist for the stimulation of NOD 1 [6] . Deprotection of the tert-butoxycarbonyl group of 9 by treatment with trifluoroacetic acid followed by condensation of the resulting amine 10 [37] with Fmoc-D-Glu-OBn [38, 39] using EDC in the presence of HOBT and triethylamine gave the protected iE-DAP 11 in 54% yield in two steps. Next, 11 was treated with diethylamine to afford the deprotected amine 12, which was subsequently acylated with capryloyl chloride and myristoyl chloride to produce the corresponding N-acyl derivatives 13 and 14 in 68% and 89% yields, respectively. Finally, the deprotection of 13 and 14 with Pd(OH) 2 as the catalyst under hydrogen gave N-capryloyl iE-DAP 15 and N-myristoyl iE-DAP 16, respectively, in quantitative yields (Scheme 2).
Scheme 2. Synthesis of N-acyl iE-DAP.

Experimental
General
Infrared (IR) spectra were recorded on a Perkin-Elmer 1600 series FT-IR spectrometer. Mass spectra (MS) were recorded on a JEOL JMN-DX 303/JMA-DA 5000 spectrometer (Tokyo, Japan). Microanalyses were performed on a Perkin-Elmer CHN 2400 Elemental Analyzer (Tokyo, Japan). Optical rotations were measured with a JASCO DIP-360 or JASCO P-1020 digital polarimeter. Proton nuclear magnetic resonance ( 1 H-NMR) spectra were recorded on JEOL JNM-EX 270 (270 MHz) or JEOL JNM-AL 400 (400 MHz) or JNM-LA (600 Mhz) spectrometer (Tokyo, Japan), using tetramethylsilane as an internal standard. The following abbreviations are used: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. Column chromatography was carried out on Merck Silica gel 60 (230-400 mesh) or KANTO Silica Gel 60N (40-50 μm) for flash chromatography. [31] (2) [32, 33] were prepared by the reported procedures.
Synthesis
(S)-tert-butyl 2,2-dimethyl-4-vinyloxazolidine-3-carboxylate (1a) [27], (S)-tert-butyl 2,2-dimethyl-4- (prop-1-en-1-yl)oxazolidine-3-carboxylate (1b) [28], (S)-tert-butyl 4-(3-ethoxy-3-oxoprop-1-en-1-yl)- 2,2-dimethyloxazolidine-3-carboxylate (1c) [29], (S)-tert-butyl 4-(3-hydroxyprop-1-en-1-yl)-2,2- dimethyloxazolidine-3-carboxylate (1d) [30], (S)-tert-butyl 2,2-dimethyl-4-styryloxazolidine-3- carboxylate (1e)
and (S)-benzyl 2-(((benzyloxy)carbonyl)amino)pent-4-enoate
(S)-tert-Butyl 4-((R)-5-(benzyloxy)-4-(benzyloxycarbonylamino)-5-oxopent-1-enyl)-2,2-dimethyloxazolidine-3-carboxylate (3), (4S,4'S)-di-tert-butyl 4,4'-((E)-ethene-1,2-diyl)bis(2,2-dimethyloxazolidine-3-carboxylate) (4), and (2R,7R,E)-dibenzyl 2,7-bis(((benzyloxy)carbonyl)amino)oct-4-enedioate (5)
To a solution of N-Cbz-(R)-allylglycine benzyl ester (124 mg, 0.36 mmol) and (Z)-(S)-N-Boc-2,2-dimethyl-4-(1-propenyl)oxazolidine (408 mg, 1.8 mmol) in dry CH 2 Cl 2 (1.8 mL) was added tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-yl-idene][benzylidine]-ruthenium (IV) dichloride (2nd Grubbs catalyst) (15 mg, 0.018 mmol). After the mixture was refluxed for 7 h, the solvent was evaporated. The residue was chromatographed using (n-hexane/AcOEt = 2:1) as eluent to yield 4 (17 mg), 3 (109 mg, 56%), and 5 (26 mg, 22%). To a solution of N-Cbz-(R)-allylglycine benzyl ester (139 mg, 0.41 mmol) and (Z)-(S)-N-Boc-2,2-dimethyl-4-(1-propenyl)oxazolidine (497 mg, 2.06 mmol) in dry toluene(3 mL) was added 2nd Grubbs catalyst (18 mg, 0.021 mmol). After the mixture was refluxed for 4 h, the solvent was evaporated. The residue was chromatographed using (n-hexane/AcOEt = 3:1) as eluent to yield 3 (168 mg, 76%).
(2R,6S)-Benzyl 2-(benzyloxycarbonylamino)-6-(tert-butoxycarbonylamino)-7-hydroxyheptanoate (6)
A mixture of 3 (263 mg, 0.49 mmol) in the presence of PtO 2 (1.8 mg, 0.02 mmol) under hydrogen atomosphere in AcOEt (3.5 mL) was stirred for 14 h at room temperature. After the mixture was filtered through Celite, the filtrate was evaporated to provide (S)-tert-Butyl 4-((R)-5-(benzyloxy)-4-(benzyloxycarbonylamino)-5-oxopentyl)-2,2-dimethyloxazolidine-3-carboxylate (6) 
. Seven drops of water were added to a mixture of carboxylic acid (299 mg, 0.55 mmol) and p-TsOH·H 2 O (0.07 mmol, 13 mg) in MeOH (5 mL) and then the mixture was stirred for 36 h at room temperature. The whole was evaporated. AcOEt (40 mL) was added to the residue. The mixture was successively washed with sat. NaHCO 3 (10 mL) and brine (10 mL), dried over Na 2 SO 4 , and evaporated. The residue was purified with chromatography using (n-hexane/AcOEt = 1:1) as eluent to yield 6 (225 mg, 81%) as solid. 
(2R,6S)-Dibenzyl 2-(benzyloxycarbonylamino)-6-(tert-butoxycarbonylamino)heptanedioate (9)
2,2,6,6-Tetramethylpiperidine 1-oxyl (TEMPO) (7 mg, 0.045 mmol) and 2 M NaClO 2 (0.43 mL, 0.86 mmol) were added to a solution of 7 (225 mg, 0.45 mmol) in MeCN: sodium phosphate buffer consisted of a 1:1 mixture of 0.67 M NaH 2 PO 4 and 0.67 M Na 2 HPO 4 (pH = 6.5 ) (3:2, 6.5 mL) at 40 °C. A diluted solution of commercial bleach (25.5 μL) in H 2 O (485 μL) was then added to the gradually over 0.5 h, and the reaction was stirred at 40 °C for 18 h. The reaction was cooled to room temperature and quenched with sat. aq. Na 2 SO 3 until the mixture became colorless. The solvent was evaporated, the aqueous mixture acidified to pH < 3 with 1 M HCl and extracted with ether (10 mL) five times. Organic layers were washed with brine, dried overNa 2 SO 4 and evaporated to yield (2S,6R)-7-(benzyloxy)-6-(((benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)-7-oxoheptanoic acid (8) . Without further purification, a mixture of 8 and BBDI (164 mg, 0.54 mmol) and benzyl alcohol (48 mg, 0.45 mmol) in CH 2 Cl 2 (2 mL) was stirred for 19 h at room temperature. AcOEt (40 mL) was added to the mixture and the whole was successively washed with 5% HCl (10 mL) and brine (10 mL). The solvent was dried over Na 2 SO 4 and evaporated. The residue was purified with chromatography using n-hexane/AcOEt (11) TFA (0.6 mL) was added to a mixture of 9 (78 mg, 0.13 mmol) in CH 2 Cl 2 (0.7 mL) and then the mixture was stirred for 2 h at room temperature. CH 2 Cl 2 (5 mL) was added to the reaction mixture and the whole neutralized with sat. NaHCO 3 . The mixture was extracted with CH 2 Cl 2 , dried over Na 2 SO 4 and evaporated to yield an amine 10. Fmoc-D-Glu benzyl ester (59 mg, 0.129 mmol) was added to a solution of the prepared amine 10 in DMF (1.5 mL). Et 3 N (20 μL, 0.142 mmol), HOBt (21 mg, 0.155 mmol), and EDC·HCl (27 mg, 0.142 mmol) were successively added to the mixture at −20 °C. The reaction was stirred for 20 min at the same temperature and then was done at room temperature for 20 h. After addition of AcOEt (100 mL), the mixture was successively washed with 1 N HCl, brine (10 mL × 2), water (10 mL), and 5% NaHCO 3 (10 mL). The organic layer was dried over Na 2 SO 4 and evaporated. The residue was purified with chromatography using (n-hexane/AcOEt = 1:1) as eluent to yield 11 (70 mg, 57%, 2 steps) as an oil. (13) Et 2 NH (2.5 mL) was gradually added to a solution of 11 (62 mg, 0.066 mmol) in THF (1 mL) with ice cooling over 20 min. The reaction was stirred at room temperature for 3 h and then was evaporated. The residue was purified with chromatography using (CHCl 3 /MeOH = 100:1) as eluent to yield (2S,6R)- and n-octanoyl chloride (9 μL, 0.053 mmol) were added to a solution of the amine 12 in CH 2 Cl 2 (1 mL) with ice cooling. The reaction was stirred at room temperature for 7 h and then evaporated. After addition of AcOEt (30 mL), the mixture was washed with 10% citric acid (10 mL) and brine (10 mL). The organic solvent was dried over Na 2 SO 4 and evaporated. The residue was purified with chromatography using (n-hexane/AcOEt = 1:1)) as eluent to yield 13 (38 mg, 68%, 2 steps) as an oil. (14) According to the procedure described for a preparation of 13, a treatment of 11 (71 mg, 0.075 mmol) with Et 2 NH (2 mL) gave 12 (39 mg, 72%), which was converted with Et 3 N (8 μL, 0.058 mmol) and myristoyl chloride (16 μL (16) A suspension of 14 (32 mg, 0.034 mmol) in the presence Pd(OH) 2 (20 mg) under hydrogen atomosphere in MeOH (1.5 mL) was stirred for 3 h. The mixture was filtered through Celite. The filtrate was evaporate to yield 16 quantitatively as an oil. IR (neat) cm 
(2S,6R)-Dibenzyl 2-((R)-4-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(benzyloxy)-5-oxopentanamido)-6-(benzyloxycarbonylamino)heptanedioate
(2S,6R)-Dibenzyl 2-((R)-4-heptanecarbonylamino-5-(benzyloxy)-5-oxopentanamido)-6-(benzyloxycarbonylamino)heptanedioate
(2S,6R)-Dibenzyl 2-((R)-4-tridecanecarbonylamino-5-(benzyloxy)-5-oxopentanamido)-6-(benzyloxycarbonylamino)heptanedioate
(2R,6S)-2-Amino-6-((R)-4-carboxy-4-tetradecanamidobutanamido)heptanedioic acid
Conclusions
In summary, a concise synthesis of N-acyl iE-DAP was accomplished starting from the protected meso-DAP 9 as a convenient synthon via the use of CM between the Garner aldehyde-derived vinyl glycine 1b and the protected allyl glycine 2 in nine steps in yields in the range of 22%~29%.
